We are live on ! Find out more
CNSY

Cerenome
CNSY

10 hedge funds and large institutions have $118K invested in Cerenome in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 6 → 10 (+4)

1.03% less ownership

Funds ownership: 4.08% → 3.06% (-1%)

43% less capital invested

Capital invested by funds: $205K → $118K (-$87.6K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
+4
Holders Change %
+66.67%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$42.4K
2
HF
HRT Financial
New York
+$24.1K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.5K
4
UBS Group
UBS Group
Switzerland
+$11.1K
5
Citigroup
Citigroup
New York
+$1.24K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$122K
2
TRCT
Tower Research Capital (TRC)
New York
-$7.03K

CNSY Hedge Fund Activity: Q3 2023 in Review

10 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q3 2023, worth a combined $118K — down 43% from $205K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CNSY positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $42.4K. The largest seller was Vanguard Group, cutting an estimated $122K.

  • 10 institutional investors held Cerenome (CNSY) as of Q3 2023, up from 6 in Q2 2023.
  • Funds reported $118K of Cerenome stock for Q3 2023, down 43% quarter-over-quarter.
  • 4 funds opened new Cerenome positions in Q3 2023 and 0 closed out, a net change of +4 holders.
  • The largest Cerenome buyer in Q3 2023 was Millennium Management, an estimated $42.4K added.
  • The largest Cerenome seller in Q3 2023 was Vanguard Group, an estimated $122K sold.

Based on aggregated 13F filings for Q3 2023.